Fevertree Drinks PLC (LON:FEVR – Get Free Report)’s stock price traded up 0.1% on Tuesday . The stock traded as high as GBX 740 ($9.45) and last traded at GBX 729 ($9.31). 471,996 shares traded hands during mid-day trading, an increase of 57% from the average session volume of 300,465 shares. The stock had previously closed at GBX 728.50 ($9.31).
Wall Street Analysts Forecast Growth
Separately, Deutsche Bank Aktiengesellschaft reduced their target price on shares of Fevertree Drinks from GBX 1,450 ($18.53) to GBX 1,325 ($16.93) and set a “buy” rating for the company in a research note on Friday, September 13th.
Fevertree Drinks Stock Performance
Fevertree Drinks Cuts Dividend
The business also recently announced a dividend, which was paid on Friday, October 18th. Shareholders of record on Thursday, September 26th were paid a dividend of GBX 5.85 ($0.07) per share. The ex-dividend date was Thursday, September 26th. This represents a yield of 0.68%. Fevertree Drinks’s payout ratio is 8,947.37%.
Fevertree Drinks Company Profile
Fevertree Drinks PLC, together with its subsidiaries, engages in the development and sale of premium mixer drinks in the United Kingdom, the United States, rest of Europe, and internationally. It offers Indian, Mediterranean, summer garden, elderflower, cucumber, damson and sloe berry, rhubarb and raspberry, aromatic, lemon, and Clementine tonic water products; pink grapefruit, soda water, raspberry and orange blossom, Mexican lime, Italian blood orange, white grape and apricot sodas; Silician, premium, and Madagascan cola and lemonades; British apple with garden mint, ginger, Sicilian lemonade, sparkling Mexican lime, Italian white grape and apricot, and light raspberry and rose lemonade softdrinks; and gingers.
Read More
- Five stocks we like better than Fevertree Drinks
- 3 Healthcare Dividend Stocks to Buy
- Survey Reveals: Which States Saw the Biggest Investment Gains in 2024?
- EV Stocks and How to Profit from Them
- Amazon’s Healthcare Gamble: A New Era of Medical Disruption
- How to Calculate Stock Profit
- Semiconductor Giant Synopsys Slides 14% — Time to Take Notice
Receive News & Ratings for Fevertree Drinks Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fevertree Drinks and related companies with MarketBeat.com's FREE daily email newsletter.